Blood cell clumps in heparin-induced low platelets
Treatments studied
Part of Blood & lymphatic clinical trials.
This study looks at how blood cells clump together in patients who may have heparin-induced thrombocytopenia (HIT), a condition where heparin causes a drop in platelets. It aims to better understand the disease and improve diagnosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You had a positive blood test for antibodies linked to HIT
- You are suspected of having HIT based on your symptoms
- You agree to join the study and sign a consent form
- You have social security coverage
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a blood-thinning medicine called cangrelor for people with a rare complication where heparin causes a dangerous drop in platelets. It may help make heart surgery safer for those who cannot use heparin.
This study looks for markers in the blood that are linked to fatigue in people with low platelets. It compares patients who have low platelets from immune or inherited causes to healthy volunteers, to understand why some feel very tired.
This study looks at whether certain antibodies and small particles in your blood can help doctors identify patients with ITP who are at risk for blood clots. It aims to improve diagnosis and prevention of clotting issues.
This study looks at blood test antibodies to help confirm whether low platelet counts are caused by an autoimmune condition. It may help doctors better classify your type of low platelets and guide appropriate next steps.
This study looks at how certain blood cell changes and immune system activity may relate to blood clots in specific veins or lungs. It may help researchers understand why clots happen “without a clear cause” and how to better predict risk.
This study tests a machine called ROTEM Sigma that measures how well your blood clots, specifically in pregnant women who have or may have low platelet counts (cells that help blood clot). The goal is to help doctors better predict bleeding problems during or after delivery.
Hear when a new Platelet Activation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.